Adam Ang
Mediwhale has recently raised $13 million in Series C funding, which will also support its entry into the United States market.
The AI decision-support system, trained on multimodal ophthalmic data, will assist in diagnosis, treatment planning, and disease monitoring and management.
It will be based on an AI model that achieved high accuracy in predicting liver metastasis using patients' routine blood tests.
Also, Zydus has introduced two AI-enabled CGM devices in India.
This comes following the launch of its ad-free medical research tool.
A 20-minute VR programme developed at Edith Cowan University uses branching scenarios to train adaptive de-escalation skills in unpredictable patient encounters.
Chinese regulators have cleared a device that helps patients with severe paralysis restore hand movement.
A new big data-based predictive model developed in Hong Kong enables more dynamic monitoring of six common cardiovascular diseases by capturing near-real-time biological changes.
Hong Kong engineers have developed an AI-powered, metamaterial-based ultrasound lens that can visualise cardiac valve structures closely behind the rib cage.
The implant enables real-time intracranial pressure monitoring, cutting hospital scans by over 60%, monitoring procedures by 90%, and reducing radiation exposure by almost half.